Beam Therapeutics Inc.
NASDAQ:BEAM
27.06 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 435.895 | 232.767 | 965.647 | 162.171 | 37.221 | 146.443 | 1.901 |
| Short Term Investments
| 753.981 | 845.367 | 405.653 | 137.5 | 54.627 | 0 | 0 |
| Cash and Short Term Investments
| 1,189.876 | 1,078.134 | 965.647 | 299.671 | 91.848 | 146.443 | 1.901 |
| Net Receivables
| 0 | 0 | 300 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -607.36 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 21.167 | 14.762 | 307.36 | 8.65 | 2.696 | 1.832 | 0.136 |
| Total Current Assets
| 1,211.043 | 1,092.896 | 965.647 | 308.321 | 94.544 | 148.275 | 2.037 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 237.806 | 234.133 | 186.976 | 125.372 | 43.247 | 16.944 | 0.335 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 8.719 | 12.754 | 12.746 | 14.84 | 13.332 | 1.493 | 0.03 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.146 | 1.931 | 309.084 | 3.144 | 4.976 | 0.3 | 0 |
| Total Non-Current Assets
| 248.671 | 248.818 | 508.806 | 143.356 | 61.555 | 18.737 | 0.365 |
| Total Assets
| 1,459.714 | 1,341.714 | 1,474.453 | 451.677 | 156.099 | 167.012 | 2.402 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.617 | 9.029 | 7.474 | 6.314 | 7.846 | 7.351 | 0.726 |
| Short Term Debt
| 13.262 | 10.38 | 7.54 | 4.218 | 4.337 | 0 | 1.01 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 68.706 | 135.974 | 86.27 | 14.234 | 6.62 | 0 | -1.01 |
| Other Current Liabilities
| 121.98 | 68.212 | 112.151 | 77.571 | 10.335 | 18.236 | 5.839 |
| Total Current Liabilities
| 205.565 | 223.595 | 213.435 | 102.337 | 29.138 | 25.587 | 6.565 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 159.911 | 168.625 | 134.81 | 96.014 | 21.187 | 0 | 0 |
| Deferred Revenue Non-Current
| 109.888 | 202.179 | 262.303 | 0.394 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -0.394 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.021 | 13.841 | 37.167 | 7.765 | 4.829 | 7.397 | 0.02 |
| Total Non-Current Liabilities
| 272.82 | 384.645 | 434.28 | 103.779 | 26.016 | 7.397 | 0.02 |
| Total Liabilities
| 478.385 | 608.24 | 647.715 | 206.116 | 55.154 | 32.984 | 6.585 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 1,474.453 | 451.677 | 302.049 | 251.434 | 5.256 |
| Common Stock
| 0.816 | 0.712 | 0.684 | 0.573 | 0.073 | 0.056 | 0.005 |
| Retained Earnings
| -1,189.889 | -1,057.362 | -768.274 | -397.636 | -203.044 | -124.718 | -9.461 |
| Accumulated Other Comprehensive Income/Loss
| 0.604 | -2.43 | -0.05 | -0.009 | 0.016 | -0.661 | -0.011 |
| Other Total Stockholders Equity
| 2,169.798 | 1,792.554 | 119.925 | 190.956 | 1.851 | 7.917 | 0.028 |
| Total Shareholders Equity
| 981.329 | 733.474 | 826.738 | 245.561 | 100.945 | 134.028 | -4.183 |
| Total Equity
| 981.329 | 733.474 | 826.738 | 245.561 | 100.945 | 134.028 | -4.183 |
| Total Liabilities & Shareholders Equity
| 1,459.714 | 1,341.714 | 1,474.453 | 451.677 | 156.099 | 167.012 | 2.402 |